DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus
Authors
Keywords
T cells, Cytotoxic T cells, Vaccination and immunization, Antiretroviral therapy, HIV-1, Adverse events, Viremia, Vaccines
Journal
PLoS One
Volume 11, Issue 10, Pages e0163164
Publisher
Public Library of Science (PLoS)
Online
2016-10-07
DOI
10.1371/journal.pone.0163164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
- (2015) Kai Deng et al. NATURE
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
- (2015) Carmen Elena Gómez et al. PLoS One
- A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
- (2015) Francesco Andrea Procopio et al. EBioMedicine
- Up-Regulation of Programmed Death-1 Expression on Beryllium-Specific CD4+ T Cells in Chronic Beryllium Disease
- (2014) B. E. Palmer et al. JOURNAL OF IMMUNOLOGY
- Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
- (2014) Paul A. Goepfert et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies
- (2014) C. Vandergeeten et al. JOURNAL OF VIROLOGY
- Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire
- (2013) Joseph P. Casazza et al. JOURNAL OF INFECTIOUS DISEASES
- Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients
- (2013) Anni A. Winckelmann et al. PLoS One
- Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
- (2013) Wolfgang Stöhr et al. PLoS One
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
- (2013) Hasina Samji et al. PLoS One
- Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
- (2013) S. G. Hansen et al. SCIENCE
- A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
- (2013) F. Garcia et al. Science Translational Medicine
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
- (2013) Asier Sáez-Cirión et al. PLoS Pathogens
- Antiretroviral Treatment of Adult HIV Infection
- (2012) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
- (2012) Yoshinori Fukazawa et al. NATURE MEDICINE
- Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection
- (2012) Jintanat Ananworanich et al. PLoS One
- No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial
- (2012) Marlous L. Grijsen et al. PLOS MEDICINE
- Regulation of Virus-Specific CD4+ T Cell Function by Multiple Costimulatory Receptors during Chronic HIV Infection
- (2010) A. Kassu et al. JOURNAL OF IMMUNOLOGY
- AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein
- (2010) Robert T. Schooley et al. JOURNAL OF INFECTIOUS DISEASES
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)
- (2009) Brigitte Autran et al. AIDS
- Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production
- (2009) Afework Kassu et al. CLINICAL IMMUNOLOGY
- Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
- (2009) Brandon F. Keele et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
- (2009) Nilu Goonetilleke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans
- (2009) David W. Haas et al. JOURNAL OF INFECTIOUS DISEASES
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
- (2008) Joseph D. Miller et al. IMMUNITY
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy
- (2008) Thomas C. Greenough et al. VACCINE
- Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
- (2007) Linda S. Wyatt et al. VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started